Clinical Trial Update: Paclitaxel and Trastuzumab With or Without Lapatinib in Treating Patients With Stage II or Stage III Breast Cancer That Can Be Removed by Surgery [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating paclitaxel and trastuzumab with or without lapatinib in patients with Stage II/III breast cancer that can be removed by surgery; result…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• HERCEPTIN (trastuzumab)
• Taxol (paclitaxel)
• Tykerb (lapatinib)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Male Breast Carcinoma, Stage IIA Breast Cancer AJCC v6 and v7 | Phase 3 | Status: COMPLETED | Results posted: 2015-05-27